Adipokine Expression Profile in Adipocytes of Different Mouse Models of Obesity

Abstract

Adipose tissue produces and secretes multiple adipokines. Most studies on adipokine production/expression have been performed on whole adipose tissue. In addition, data concerning an overall of adipokine expression are scarce and can be heterogeneous depending on the obesity model studied. Our first aim was to compare the expression of adipokines involved in the interplay between obesity and insulin resistance in isolated adipocytes from different mouse models of obesity displaying different levels of weight gain and insulin sensitivity. The second aim was to determine perigonadal/subcutaneous ratio of each adipokine. Only resistin expression was decreased in obese mice without modifications in glucose and insulin blood levels. In addition to decreased levels of resistin, obesity models associated with hyperglycemia and hyperinsulinemia presented an increased expression of leptin and tumor necrosis factor-alpha (TNFα). Obese and diabetic mice were the only animals to exhibit high expression of plasminogen activator inhibitor type-1 and interleukin-6. All adipokines except TNFα were more heavily expressed in perigonadal than in subcutaneous adipocytes. Interestingly, fat-enriched diet and overweight on their own did not modify the distribution of adipokines between the two fat depots. However, severe obesity modified the distribution of proinflammatory adipokines. In conclusion, the level and number of adipokines with altered expression increased with obesity and hyperinsulinemia in mice. The physiopathological impact of depot-specific differences of adipokine expression in adipocytes remains to be clarified.

Insulin resistance · gene expression · fat depot · adipose tissue

References

• 1 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.  Proc Nutr Soc. 2001;  60 329-339
• 2 Kershaw E E, Flier J S. Adipose tissue as an endocrine organ.  J Clin Endocrinol Metab. 2004;  89 2548-2556
• 3 Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance.  Diabetologia. 2003;  46 1594-1603
• 4 Jazet I M, Meinders A E. Adipose tissue as an endocrine organ: impact on insulin resistance.  Neth J Med. 2003;  61 194-212
• 5 Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endoc.  Rev. 2000;  21 697-738
• 6 Valet P, Grujic D, Wade J, Ito M, Zingaretti M C, Soloveva V, Ross S R, Graves R A, Cinti S, Lafontan M, Lowell B B. Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity.  J Biol Chem. 2000;  275 34 797-34 802
• 7 Debons A F, Krimsky I, Maayan M L, Fani K, Jemenez F A. Gold thioglucose obesity syndrome.  Fed Proc. 1977;  36 143-177
• 8 Kodama H, Fujita M, Yamaguchi H. Development of hyperglycaemia and insulin reistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice.  Diabetologia. 1994;  37 739-744
• 9 Guerre-Millo M. Adipose tissue and adipokines: for better or worse.  Diabetes Metab. 2004;  30 13-19
• 10 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
• 11 Kern P A, DiGregorio G B, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.  Diabetes. 2003;  52 1779-1785
• 12 Russel C D, Ricci M R, Brolin R E, Magill E, Fried S K. Regulation of the leptin content of obese human adipose tissue.  Am J Physiol Endocrinol Metab. 2001;  280 E399-E404
• 13 Makimura H, Mizuno T M, Bergen H, Mobbs C V. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.  Am J Physiol Endocrinol Metab. 2002;  283 E1266-E1271
• 14 Fain J N, Madan A K, Hiler M L, Paramjeet C, Bahouth S W. Comparison of the release of adipokines by adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.  Endocrinology. 2004;  145 2273-2282
• 15 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
• 16 Way J M, Gorgun C Z, Tong Q, Uysal K T, Brown K K, Harrington W W, Oliver W R Jr, Willson T M, Kliewer S A, Hotamisligil G S. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.  J Biol Chem. 2001;  276 25 651-25 653
• 17 Le Lay S, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, Valet P, Dugail I. Decreased resistin expression in mice with different sensitivities to a high-fat diet.  Biochem Biophys Res Commun. 2001;  289 564-567
• 18 Rajala M W, Qi Y, Patel H R, Takahashi N, Banerjee R R, Pajvani U B, Sinha M K, Gingerich R L, Scherer P E, Ahima R S. Regulation of resistin expression and circulating levels in obesity, diabetes and fasting.  Diabetes. 2004;  53 1671-1679
• 19 Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.  Science. 1993;  259 87-91
• 20 Ruan H, Lodish H F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-a.  Cytokine Growth Factor Rev. 2003;  14 447-455
• 21 Kern P A, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.  Am J Physiol Endocrinol Metab. 2001;  280 E745-E751
• 22 Bastard J P, Maachi M, Van Nhieu J T, Jardel C, Bruckert E, Grimaldi A, Robert J J, Capeau J, Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.  J Clin Endocrinol Metab. 2002;  87 2084-2089
• 23 Mertens I, Van Gaal L F. Obesity, haemostasis and the fibrinolytic system.  Obes Rev. 2002;  3 85-101
• 24 Samad F, Yamamoto K, Loskutoff D J. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.  J Clin Invest. 1996;  97 37-46
• 25 Trayhurn P, Wood I S. Adipokines: inflammation and the pleiotropic role of white adipose tissue.  Br J Nutr. 2004;  92 347-355
• 26 Ruan H, Miles P D, Ladd C M, Ross K, Golub T R, Olefsky J M, Lodish H F. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance.  Diabetes. 2002;  51 3176-3188
• 27 Zheng D, Wooter M H, Zhou Q, Dohm G L. The effect of exercise on ob gene expression.  Biochem Biophys Res Commun. 1996;  225 747-750
• 28 Atzmon G, Yang X M, Muzumdar R, Ma X H, Gabriely I, Barzilai N. Differential gene expression between visceral and subcutaneous fat depots.  Horm Metab Res. 2002;  34 622-628
• 29 Altomonte J, Harbaran S, Richter A, Dong H. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats.  Metabolism. 2003;  52 958-963
• 30 Voros G, Maquoi E, Collen D, Lijnen H R. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-a, TNF-a converting enzyme and ADAMTS family members in murine fat territories.  Biochim Biophys Acta. 2003;  1625 36-42